NovaDigm Therapeutics, Inc.
Industry
- Pharmaceuticals
- Vaccines
- Biotechnology
- Large Molecule
Latest on NovaDigm Therapeutics, Inc.
The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer
The global vaccine market is on a tear, growing at an annual rate of 11.5%, far outstripping drugs and devices. Although 80% of the $30 billion market is held by Merck & Co. Inc. , Sanofi , Gl
PHARMACEUTICALS Inovio Pharmaceuticals Inc. Fudan University Shanghai Medical College Inovio gets Alzheimer’s, MS preclinical candidates from Shanghai Medical College Fudan University ’s S
IN VITRO DIAGNOSTICS Genetic Analysis AS Genetic Analysis closes $2mm financing Norwegian molecular diagnostics firm Genetic Analysis AS raised $2mm in an early-stage financing to Norsk Innova